VAISHALI PHARMA
Back to Balance Sheet
|
VAISHALI PHARMA Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4.69 Cr | ₹3.86 Cr | ₹6.16 Cr | ₹3.17 Cr | ₹4.30 Cr |
What is the latest Total Non-Current Liabilities ratio of VAISHALI PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹4.69 Cr |
| Mar2024 | ₹3.86 Cr |
| Mar2023 | ₹6.16 Cr |
| Mar2022 | ₹3.17 Cr |
| Mar2021 | ₹4.30 Cr |
How is Total Non-Current Liabilities of VAISHALI PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.69 Cr | 21.59 | |
| Mar2024 | ₹3.86 Cr | -37.30 | |
| Mar2023 | ₹6.16 Cr | 94.04 | |
| Mar2022 | ₹3.17 Cr | -26.16 | |
| Mar2021 | ₹4.30 Cr | - | |
Compare Total Non-Current Liabilities of peers of VAISHALI PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VAISHALI PHARMA | ₹79.9 Cr | -6% | -24.2% | -53.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
VAISHALI PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | -6% |
-24.2% |
-53.3% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses